You are here: Industry Insights > melanoma

News List

Combining drugs that target BRAF and HSP90 shows success for melanoma patients europeanpharmaceuticalreview
April 26, 2018
Scientists have tried combining drugs in an effort to prevent resistance development that eventually leads to cancer regrowth in melanoma patients.
Incyte Nosedives: Drug Combo Fails Melanoma Phase III Trial biospace
April 08, 2018
Shares of Incyte Corporation are down more than 20 percent this morning after the company revealed that pairing is IDO1 drug in combination with Merck’s Keytruda failed to meet endpoints in a Phase III melanoma trial.
Array BioPharma Touts Phase III Results for Melanoma Therapy biospace
March 23, 2018
Shares of Array BioPharma, Inc. are climbing this morning after the company released detailed results for its late-stage combination treatment for metastatic melanoma.
Independent Study Demonstrates Significant and Risk-Appropriate Clinical Impact of DecisionDx-Melano biospace
March 22, 2018
Castle Biosciences, Inc., today announced the publication of results from an independent study of the DecisionDx®-Melanoma gene expression profile test’s impact on clinical decision-making
MK-8353 shows promise for melanoma with BRAF or RAS mutations europeanpharmaceuticalreview
February 28, 2018
An investigational compound designed to block a hyperactive cell growth signal in advanced melanoma and other cancers has shown some promise in an early-stage clinical trial…
Mid-infrared spectroscopy used to diagnose lymphoma and melanoma europeanpharmaceuticalreview
December 14, 2017
A blood test using infrared spectroscopy can be used to diagnose two types of cancer…
Nivolumab superior to ipilimumab for adjuvant treatment of melanoma europeanpharmaceuticalreview
September 13, 2017
Adjuvant nivolumab has been found to be more superior than ipilimumab in the standard of care in patients with surgically resected stage III/IV melanoma…
Immunotherapy combination safe and 62 percent effective in metastatic melanoma patients worldpharmanews
September 08, 2017
Immunotherapy is a promising approach in the treatment of metastatic melanoma, an aggressive and deadly form of skin cancer; but for most patients, immunotherapy drugs so far have failed to live up to their promise and provide little or no benefit.
Researchers identify key trigger in melanoma progression pharmafile
May 04, 2017
Researchers from life sciences research institute VIB and KU Leuven in Belgium in collaboration with INSERM, the French...

Previous page 1 2 3 4 5 6 7 Next page